Plain-English translation of NCT07148414 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase 2 study testing a new medication called for adults with three types of active joint diseases: rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis. The study is designed to see whether this treatment works better than a placebo (a dummy pill) and to understand its safety. Researchers are specifically looking for people whose disease remains active despite already taking other arthritis medications.
Many people with these types of arthritis don't improve enough with current medications, or their disease comes back even while on treatment. This study is testing whether this new medication could offer another option for people who need better disease control.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to receive either the new medication or a placebo by mouth in a blinded study (meaning neither you nor the researchers will initially know which group you're in). Some participants testing the medication may receive different doses. You'll have regular visits to the clinic where your arthritis symptoms will be measured through joint counts, blood tests, and questionnaires about how you're feeling. The study is designed to follow participants over several weeks to months to see how well the treatment works and to monitor for any side effects.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States